Please use this identifier to cite or link to this item:
|Title:||Role of thymosin β4 on skeletal myoblast migration, proliferation, and survival|
|Citation:||Ye, L.,Su, L.-P.,Pi, W.-F.,Law, P.K. (2012-05). Role of thymosin β4 on skeletal myoblast migration, proliferation, and survival. Recent Patents on Regenerative Medicine 2 (2) : 146-155. ScholarBank@NUS Repository.|
|Abstract:||Massive cell death associated with poor donor cell survival was a limiting factor in the success of myoblast transfer therapy (MTT). The current study is aimed to determine the effects of thymosin β4 on human skeletal myoblast (hSkM) migration, proliferation and survival under hypoxia. hSkM was cultured in basal medium (BM, M199 medium with 10% fetal bovine serum) supplemented with various concentrations of thymosin β4. Supernatant was collected to test the toxicity of thymosin β4 towards hSkM. Cell number was quantified using CyQuant cell proliferation assay kit. Cell viability was determined by calculating the lactate dehydrogenase (LDH) in the supernatant. hSkM migration was determined using cell culture insert. No significant toxicity of thymosin β4 towards hSkM was found when thymosin β4 was increased up to 600ng/ml. Thymosin βincreased hSkM proliferation rate by 35.4+13.4% at 600ng/ml. It enhanced hSkM viability (cell injury =10.9±1.7%) as compared with control (cell injury = 24.6%, p < 0.05) under hypoxia (5% CO2+ 94% N2+1% O2) for 48 hours (hrs). Increased migration rate (164.5+15/well, p|
|Source Title:||Recent Patents on Regenerative Medicine|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Oct 26, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.